These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 34579023)

  • 1. Diet in Intestinal Fibrosis: A Double-Edged Sword.
    Marion-Letellier R; Leboutte M; Amamou A; Raman M; Savoye G; Ghosh S
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic modulation during intestinal fibrosis.
    Bos S; Laukens D
    J Dig Dis; 2020 Jun; 21(6):319-325. PubMed ID: 32406133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological Regulation of Intestinal Fibrosis in Inflammatory Bowel Disease.
    Bamias G; Pizarro TT; Cominelli F
    Inflamm Bowel Dis; 2022 Mar; 28(3):337-349. PubMed ID: 34904152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mechanisms and clinical trial endpoints in intestinal fibrosis.
    Wang J; Lin S; Brown JM; van Wagoner D; Fiocchi C; Rieder F
    Immunol Rev; 2021 Jul; 302(1):211-227. PubMed ID: 33993489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can we prevent, reduce or reverse intestinal fibrosis in IBD?
    Latella G; Sferra R; Speca S; Vetuschi A; Gaudio E
    Eur Rev Med Pharmacol Sci; 2013 May; 17(10):1283-304. PubMed ID: 23740440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cytokine and immune responses in intestinal fibrosis.
    Yang B; Zhang G; Elias M; Zhu Y; Wang J
    J Dig Dis; 2020 Jun; 21(6):308-314. PubMed ID: 32410365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of tissue remodeling in inflammatory bowel disease.
    Rieder F; Fiocchi C
    Dig Dis; 2013; 31(2):186-93. PubMed ID: 24030223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of non-inflammatory factors in intestinal fibrosis.
    Zhao JF; Ling FM; Li JR; Chen YD; Huang L; Zhu LR
    J Dig Dis; 2020 Jun; 21(6):315-318. PubMed ID: 32406603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary salt exacerbates intestinal fibrosis in chronic TNBS colitis via fibroblasts activation.
    Amamou A; Rouland M; Yaker L; Goichon A; Guérin C; Aziz M; Savoye G; Marion-Letellier R
    Sci Rep; 2021 Jul; 11(1):15055. PubMed ID: 34301970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of Intestinal Fibrosis in Inflammatory Bowel Disease and Perspectives for Therapeutic Implication.
    Bettenworth D; Rieder F
    Dig Dis; 2017; 35(1-2):25-31. PubMed ID: 28147352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversial Contribution of Th17/IL-17 Toward the Immune Response in Intestinal Fibrosis.
    Latella G; Viscido A
    Dig Dis Sci; 2020 May; 65(5):1299-1306. PubMed ID: 32124197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin attenuates intestinal fibrosis independent of the anti-inflammatory effect by promoting fibroblast/myofibroblast apoptosis in the regeneration/healing process from TNBS-induced colitis.
    Abe Y; Murano M; Murano N; Morita E; Inoue T; Kawakami K; Ishida K; Kuramoto T; Kakimoto K; Okada T; Narabayashi K; Umegaki E; Higuchi K
    Dig Dis Sci; 2012 Feb; 57(2):335-44. PubMed ID: 21909991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifiable Environmental Factors in Inflammatory Bowel Disease.
    Burke KE; Boumitri C; Ananthakrishnan AN
    Curr Gastroenterol Rep; 2017 May; 19(5):21. PubMed ID: 28397132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the 4th scientific workshop of the ECCO (Group II): markers of intestinal fibrosis in inflammatory bowel disease.
    Rieder F; de Bruyn JR; Pham BT; Katsanos K; Annese V; Higgins PD; Magro F; Dotan I
    J Crohns Colitis; 2014 Oct; 8(10):1166-78. PubMed ID: 24726695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal fibrosis in IBD--a dynamic, multifactorial process.
    Rieder F; Fiocchi C
    Nat Rev Gastroenterol Hepatol; 2009 Apr; 6(4):228-35. PubMed ID: 19347014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Targeting of Intestinal Fibrosis in Crohn's Disease.
    Santacroce G; Lenti MV; Di Sabatino A
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD.
    Latella G; Rogler G; Bamias G; Breynaert C; Florholmen J; Pellino G; Reif S; Speca S; Lawrance IC
    J Crohns Colitis; 2014 Oct; 8(10):1147-65. PubMed ID: 24731838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity of local inflammation does not impact development of fibrosis in mouse models of intestinal fibrosis.
    Hünerwadel A; Fagagnini S; Rogler G; Lutz C; Jaeger SU; Mamie C; Weder B; Ruiz PA; Hausmann M
    Sci Rep; 2018 Oct; 8(1):15182. PubMed ID: 30315190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases.
    Rieder F; Fiocchi C; Rogler G
    Gastroenterology; 2017 Feb; 152(2):340-350.e6. PubMed ID: 27720839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Umbilical cord/placenta-derived mesenchymal stem cells inhibit fibrogenic activation in human intestinal myofibroblasts via inhibition of myocardin-related transcription factor A.
    Choi YJ; Koo JB; Kim HY; Seo JW; Lee EJ; Kim WR; Cho JY; Hahm KB; Hong SP; Kim DH; Yoo JH
    Stem Cell Res Ther; 2019 Sep; 10(1):291. PubMed ID: 31547873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.